For the Inventor, By the Inventor

Enter assignee name

Pola Pharma Inc.

USPTO Granted Patents = 33

% Expired Patents = 21.2

EPO Patents = 18

Forward Citations = 37

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Takaaki Masuda (15 out of 15 patents)

Nobuo Kubota (13 out of 13 patents)

Hirokazu Kobayashi (11 out of 30 patents)

4. Naoko Kobayashi (9 out of 9 patents)

5. Azuma Nishio (8 out of 9 patents)

6. Yasushi Murakami (6 out of 14 patents)

7. Hideaki Sasagawa (5 out of 5 patents)

8. Akira Nozawa (5 out of 10 patents)

9. Madoka Ito (3 out of 7 patents)

10. Hideo Kaneda (3 out of 10 patents)

11. Hiroshi Yamaguchi (3 out of 73 patents)

12. Kahori Fujii (2 out of 2 patents)

13. Eiko Kosugi (2 out of 2 patents)

14. Naoto Nishida (2 out of 6 patents)

15. Yoshiyuki Miyata (2 out of 2 patents)

33 patents: Sort by Forward Citations

1. 11135297 - External-use composition producing foamed state upon use (2021-10-05),

2. 11090234 - Foam, screen foamer composition, and evaluation method for same (2021-08-17),

3. 10265268 - External composition for screen foamers (2019-04-23),

4. 10130610 - Antimycotic pharmaceutical composition (2018-11-20),

5. 9968591 - Antifungal composition (2018-05-15),

6. 9562912 - Method of identifying abnormal cells by expression levels of ETFB (2017-02-07),

7. 9527836 - Crystal having specific crystal habit and pharmaceutical composition containing the crystal as active ingredient (2016-12-27),

8. 9491933 - Infected nail of animal infected with fungus (2016-11-15),

9. 9480746 - Resin container filled with antifungal pharmaceutical composition (2016-11-01),

10. 9480678 - Antifungal pharmaceutical composition (2016-11-01),

11. 9453006 - Crystalline form having specific crystal habit and pharmaceutical composition containing this crystalline form as active ingredient (2016-09-27),

12. 9199977 - Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal (2015-12-01),

13. 9145401 - Amide derivative and use of the same as stability index of a luliconazole pharmaceutical formulation (2015-09-29),

14. 9085554 - Method of evaluating pharmaceutical preparation containing luliconazole and index substance (2015-07-21),

15. 9068958 - Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal (2015-06-30),

POLA PHARMA INC. is a pharmaceutical company based in Japan. They specialize in the research, development, and manufacturing of innovative healthcare products. With a focus on improving the quality of life for individuals, POLA PHARMA INC. strives to contribute to society through their advanced pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

33 Patents

#1,018 in Tokyo

#2,196 in Japan

#20,094 in the World

Pola Pharma Inc.

Forward Citations = 37

27 inventors:

Takaaki Masuda (15 out of 15 patents)

Nobuo Kubota (13 out of 13 patents)

Hirokazu Kobayashi (11 out of 30 patents)

4. Naoko Kobayashi (9 out of 9 patents)

5. Azuma Nishio (8 out of 9 patents)

Please report any incorrect information to [email protected]

Loading…